National Cancer Institute (NCI): Neoplasms trials

The registry lists 318 Neoplasms studies with National Cancer Institute (NCI) as lead sponsor. 27 are open to participants now and 76 have results posted.

Early Phase 1 3Phase 1 178Phase 2 89Phase 3 2No phase 66(a study in two phases counts in both)

Studies

Page 3 of 4. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Early Detection of Esophageal CancerTerminatedNCT00341523
• Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With GeneticsCompletedNCT00341458
• Esophageal Cancer Genetics StudiesCompletedNCT00341276
• Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening TrialActive, not recruitingNCT00339495
• Ixabepilone in Treating Young Patients With Refractory Solid TumorsCompletedNCT00331643Phase 2
• AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS TumorsCompletedNCT00326664Phase 1
• Vorinostat and Alvocidib in Treating Patients With Advanced Solid TumorsCompletedNCT00324480Phase 1
• Combination Chemotherapy in Treating Young Patients With Advanced Solid TumorsCompletedNCT00281944Phase 1
• Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced CancerCompletedNCT00244972Phase 1
• Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaCompletedNCT00217412Phase 1
• SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00121290Phase 1
• 17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00121264Phase 1
• 17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00119236Phase 1
• A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1aCompletedNCT00117013Phase 1
• Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid TumorsTerminatedNCT00112684Phase 1
• Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain TumorsTerminatedNCT00110032Phase 1
• SJG-136 in Treating Patients With Advanced Solid TumorsCompletedNCT00103220Phase 1
• Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
• Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS TumorsCompletedNCT00100880Phase 1
• CCI-779 and EKB-569 in Treating Patients With Advanced Solid TumorsCompletedNCT00098501Phase 1
• Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid TumorsCompletedNCT00093821Phase 1
• Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
• Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
• Bortezomib in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00091117Phase 1
• EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
• Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid TumorsTerminatedNCT00086983Phase 1
• Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid TumorsTerminatedNCT00086970Phase 1
• Bevacizumab in Treating Young Patients With Refractory Solid TumorsCompletedNCT00085111Phase 1
• Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsTerminatedNCT00084461Phase 2
• Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell NeoplasmsCompletedNCT00082784Phase 1
• Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid TumorsCompletedNCT00080990Phase 1
• GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00078962Phase 1
• Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsCompletedNCT00077454Phase 1
• Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine TumorsCompletedNCT00075439Phase 2
• Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid TumorsCompletedNCT00074321Phase 1
• Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid TumorsCompletedNCT00072436Phase 1
• A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced MalignanciesCompletedNCT00068484Phase 1
• Voriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyCompletedNCT00066599Phase 2
• Radiation Therapy and the Natural History of Childhood CancersCompletedNCT00064883
• Cilengitide in Treating Children With Refractory Primary Brain TumorsCompletedNCT00063973Phase 1
• Irinotecan and Thalidomide in Treating Patients With Advanced Solid TumorsCompletedNCT00062127Phase 1
• Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid TumorsCompletedNCT00055809Phase 2
• Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid TumorsCompletedNCT00054548Phase 1
• Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial NeoplasiaCompletedNCT00054041Phase 2
• FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaCompletedNCT00053963Phase 1
• Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsCompletedNCT00052780Phase 1
• Bortezomib and Docetaxel in Treating Patients With Advanced Solid TumorsTerminatedNCT00049088Phase 1
• Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00047047Phase 1
• E7389 in Treating Patients With Advanced Solid TumorsCompletedNCT00047034Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00046917Phase 1
• Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic RiskCompletedNCT00043472
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00042874Phase 1
• Gefitinib in Treating Children With Refractory Solid TumorsCompletedNCT00040781Phase 1
• Gefitinib and Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00039390Phase 1
• UCN-01 and Carboplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00036777Phase 1
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of ChildhoodCompletedNCT00030667Phase 2
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
• Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00030368Phase 1
• 2-Methoxyestradiol in Treating Patients With Advanced Solid TumorsCompletedNCT00030095Phase 1
• BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid TumorsTerminatedNCT00028561Phase 1
• Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00027898Phase 1
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney FailureCompletedNCT00026169Phase 1
• SU6668 in Treating Patients With Advanced Solid TumorsCompletedNCT00024206Phase 1
• EMD 121974 in Treating Patients With Advanced Solid TumorsCompletedNCT00022113Phase 1
• Bortezomib in Treating Children With Advanced Solid TumorsCompletedNCT00021216Phase 1
• Temozolomide and O6-benzylguanine in Treating Children With Solid TumorsCompletedNCT00020150Phase 1
• Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic CancerCompletedNCT00019656Phase 1
• Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNCT00019630Phase 1
• Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsCompletedNCT00019331Phase 2
• Vaccine Therapy in Treating Patients With Multiple MyelomaCompletedNCT00019097Phase 2
• Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal MethotrexateCompletedNCT00018967Not applicable
• KRN5500 in Treating Patients With Solid TumorsCompletedNCT00017238Phase 1
• Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic MalignanciesCompletedNCT00013533Early Phase 1
• 7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid TumorsTerminatedNCT00012194Phase 1
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
• Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid TumorsCompletedNCT00007917Phase 1
• Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00007878Phase 1
• BMS-214662 in Treating Patients With Advanced Solid TumorsCompletedNCT00006242Phase 1
• SU5416 and Carboplatin to Treat Ovarian CancerCompletedNCT00006155Phase 1
• Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00006102Phase 2
• BMS-214662 in Treating Patients With Solid TumorsCompletedNCT00005973Phase 1
• Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial NeoplasiaTerminatedNCT00005808Phase 1
• Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced CancerTerminatedNCT00005655Phase 1
• Gemcitabine in Treating Children With Refractory Solid TumorsCompletedNCT00005577Phase 1
• Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium BacteriaCompletedNCT00004988Phase 1
• Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00004919Phase 1
• Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive ChemotherapyCompletedNCT00004853Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00004242Phase 1
• Endostatin in Treating Patients With Advanced Solid TumorsCompletedNCT00004229Phase 1
• Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00004079Phase 1
• Irofulven in Treating Children With Recurrent or Refractory Solid TumorsCompletedNCT00003370Phase 1
• Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid TumorsCompletedNCT00003288Phase 1
• Oxaliplatin in Cancer Patients With Impaired Kidney FunctionCompletedNCT00001835Phase 1
• Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of SamplesCompletedNCT00001814
• A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabCompletedNCT00001805Phase 2
• Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and TyrosinaseCompletedNCT00001685Phase 2
• A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the LiverCompletedNCT00001587Phase 1
• A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the LiverCompletedNCT00001576Phase 1
• A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of OrganochlorinesCompletedNCT00001571